Pharmaceutical Technology13h
Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn
Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...
Bain Capital buys Japanese pharma for $3.3B
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
US equities fall as hopes for lower rates fade again
Moderating job growth, rising inflation expectations and the prospect of reciprocal tariffs knocked the wind out of Wall ...
BioPharma Dive17h
Bain buys Mitsubishi pharma unit; Bausch + Lomb deal talks come up empty
The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...
China Investment Map Shows Expansion Into New Counties Amid USAID Upheaval
Supporters of the move believe USAID was poorly managed and wasting taxpayers' money, with White House Press Secretary ...
MBK Partners-Led Consortium Acquires Japanese Semiconductor Company FICT In $660 Million Deal
The North Asian private equity giant cited rising demand for semiconductor products amid the AI boom for its decision to ...
Bain Capital to Buy Mitsubishi Chemical’s Pharma Business for More Than $3 Billion
The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...